These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 29764768)
1. Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway. Zou Q; Hou Y; Wang H; Wang K; Xing X; Xia Y; Wan X; Li J; Jiao B; Liu J; Huang A; Wu D; Xiang H; Pawlik TM; Wang H; Lau WY; Wang Y; Shen F EBioMedicine; 2018 May; 31():287-298. PubMed ID: 29764768 [TBL] [Abstract][Full Text] [Related]
2. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma. Iwagami Y; Huang CK; Olsen MJ; Thomas JM; Jang G; Kim M; Lin Q; Carlson RI; Wagner CE; Dong X; Wands JR Hepatology; 2016 Apr; 63(4):1213-26. PubMed ID: 26683595 [TBL] [Abstract][Full Text] [Related]
3. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763 [TBL] [Abstract][Full Text] [Related]
4. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma. Tomimaru Y; Mishra S; Safran H; Charpentier KP; Martin W; De Groot AS; Gregory SH; Wands JR Vaccine; 2015 Mar; 33(10):1256-66. PubMed ID: 25629522 [TBL] [Abstract][Full Text] [Related]
5. INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma. Zhou Q; Lin J; Yan Y; Meng S; Liao H; Chen R; He G; Zhu Y; He C; Mao K; Wang J; Zhang J; Zhou Z; Xiao Z J Exp Clin Cancer Res; 2022 Jan; 41(1):13. PubMed ID: 34996491 [TBL] [Abstract][Full Text] [Related]
6. A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma. Aihara A; Huang CK; Olsen MJ; Lin Q; Chung W; Tang Q; Dong X; Wands JR Hepatology; 2014 Oct; 60(4):1302-13. PubMed ID: 24954865 [TBL] [Abstract][Full Text] [Related]
7. Aspartate β-hydroxylase (ASPH) Accelerates Intrahepatic Cholangiocarcinoma Metastasis Zou Y; Lin J; Liu J; Zhang F; Yang T; Gong J; Jiang T; Zuo J; Song R; Shen H; Shen F; Li J Curr Protein Pept Sci; 2023; 24(5):436-446. PubMed ID: 37132101 [TBL] [Abstract][Full Text] [Related]
8. Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma. Shimoda M; Tomimaru Y; Charpentier KP; Safran H; Carlson RI; Wands J J Hepatol; 2012 May; 56(5):1129-1135. PubMed ID: 22245894 [TBL] [Abstract][Full Text] [Related]
9. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Bai X; Sun B; Hung MC; Liu L; Wands J; Dong X Mol Cancer; 2019 Nov; 18(1):156. PubMed ID: 31694640 [TBL] [Abstract][Full Text] [Related]
10. Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis. Nagaoka K; Ogawa K; Ji C; Cao KY; Bai X; Mulla J; Cheng Z; Wands JR; Huang CK Dig Dis Sci; 2021 Apr; 66(4):1080-1089. PubMed ID: 32445050 [TBL] [Abstract][Full Text] [Related]
11. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma. Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929 [TBL] [Abstract][Full Text] [Related]
12. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131 [TBL] [Abstract][Full Text] [Related]
13. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Zhang C; Guo F; Xu G; Ma J; Shao F Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update. Hou G; Xu B; Bi Y; Wu C; Ru B; Sun B; Bai X Bosn J Basic Med Sci; 2018 Nov; 18(4):297-304. PubMed ID: 30179586 [TBL] [Abstract][Full Text] [Related]
15. HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial-mesenchymal transition via the NF-κB pathway. Hu YL; Feng Y; Ma P; Wang F; Huang H; Guo YB; Li P; Mao QS; Xue WJ Exp Cell Res; 2019 Aug; 381(1):66-76. PubMed ID: 31047882 [TBL] [Abstract][Full Text] [Related]
16. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875 [TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-β signaling-induced epithelial-mesenchymal transition. Qiu C; Liu Y; Mei Y; Zou M; Zhao Z; Ye M; Wu X Aging (Albany NY); 2018 Oct; 10(10):2783-2799. PubMed ID: 30335615 [TBL] [Abstract][Full Text] [Related]
18. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma. Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550 [TBL] [Abstract][Full Text] [Related]
19. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling. Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700 [TBL] [Abstract][Full Text] [Related]
20. Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation. Huang CK; Iwagami Y; Zou J; Casulli S; Lu S; Nagaoka K; Ji C; Ogawa K; Cao KY; Gao JS; Carlson RI; Wands JR Cancer Lett; 2018 Aug; 429():1-10. PubMed ID: 29733964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]